Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Generated: April 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019414

« Back to Dashboard

NDA 019414 describes CARDIOGEN-82, which is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. Additional details are available on the CARDIOGEN-82 profile page.

The generic ingredient in CARDIOGEN-82 is rubidium chloride rb-82. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the rubidium chloride rb-82 profile page.
Summary for 019414
Ingredient:rubidium chloride rb-82
Formulation / Manufacturing:see details
Pharmacology for NDA: 019414
Mechanism of ActionRadiopharmaceutical Activity
Suppliers and Packaging for NDA: 019414
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414 NDA Bracco Diagnostics Inc 0270-0091 0270-0091-01 1 INJECTION, SOLUTION in 1 PACKAGE (0270-0091-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Dec 29, 1989TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.